Cargando…
MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma
OBJECTIVE: This study was performed to examine serum microRNA-375 (miR-375) expression in patients with osteosarcoma and determine its diagnostic and prognostic value. METHODS: Serum samples were obtained from 95 patients with osteosarcoma and 95 healthy individuals. miR-375 expression was detected...
Autores principales: | Liu, Wei, Zhao, XiaoTao, Zhang, Ying-Jian, Fang, Guang-Wen, Xue, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972241/ https://www.ncbi.nlm.nih.gov/pubmed/29115164 http://dx.doi.org/10.1177/0300060517734114 |
Ejemplares similares
-
Identification of plasma microRNA-22 as a marker for the diagnosis,
prognosis, and chemosensitivity prediction of osteosarcoma
por: Diao, Zhen-bin, et al.
Publicado: (2020) -
MicroRNA‐375‐3p enhances chemosensitivity to 5‐fluorouracil by targeting thymidylate synthase in colorectal cancer
por: Xu, Fei, et al.
Publicado: (2020) -
Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma
por: Lai, N-s, et al.
Publicado: (2015) -
MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib
por: Lassalle, Sandra, et al.
Publicado: (2016) -
Serum microRNA-17 functions as a prognostic biomarker in osteosarcoma
por: Li, Shuai, et al.
Publicado: (2016)